miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment

被引:0
|
作者
Anajafi, Sara [1 ]
Paryan, Mahdi [2 ]
Khoshnazar, Amineh [1 ]
Soleimani, Masoud [3 ]
Mohammadi-Yeganeh, Samira [1 ,3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran
[2] Pasteur Inst Iran, Dept Res & Dev, Prod & Res Complex, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Med Nanotechnol & Tissue Engn Res Ctr, Tehran, Iran
关键词
miRNA; cancer-associated fibroblasts (CAF); tumor microenvironment; signaling pathways; drug delivery; drug resistance; PARACRINE TGF-BETA; TUMOR MICROENVIRONMENT; CISPLATIN RESISTANCE; EXPRESSION ANALYSIS; ANTICANCER DRUGS; PANCREATIC TUMOR; CELL-MIGRATION; LUNG-CANCER; STEM-CELLS; PROMOTE;
D O I
10.2174/1871530323666230823094556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer-associated fibroblasts (CAFs) as a major component of cancer stroma contribute to diverse procedures of most solid tumors and might be a targeted cancer therapy approach. Their specified features, related signaling pathways, distinct biomarkers, and sub-populations need to be deciphered. There is a need for CAF extraction or induction for in vitro investigations. Some miRNAs could activate CAF-like phenotype and they also interfere in CAF-mediated drug resistance, aggressiveness, and metastatic behaviors of several cancer cell types. Due to the complex relevance of miRNA and CAFs, these non-coding oligonucleotides may serve as attractive scope for anti-cancer targeted therapies, but the lack of an efficient delivery system is still a major hurdle. Here, we have summarized the investigated information on CAF features, isolation, and induction procedures, and highlighted the miRNA-CAF communications, providing special insight into nano-delivery systems.
引用
收藏
页码:333 / 347
页数:15
相关论文
共 50 条
  • [1] The cancer-associated fibroblasts and drug resistance
    Li, X. -Y.
    Hu, S. -Q.
    Xiao, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (11) : 2112 - 2119
  • [2] miRNAs derived from cancer-associated fibroblasts in colorectal cancer
    Savardashtaki, Amir
    Shabaninejad, Zahra
    Movahedpour, Ahmad
    Sahebnasagh, Roxana
    Mirzaei, Hamed
    Hamblin, Michael R.
    EPIGENOMICS, 2019, 11 (14) : 1627 - 1645
  • [3] Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment
    Kim, Mi-Gyeong
    Shon, Yuna
    Kim, Jinyoung
    Oh, Yu-Kyoung
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [4] Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment
    Kim, Iljin
    Choi, Sanga
    Yoo, Seongkyeong
    Lee, Mingyu
    Kim, In-San
    CANCERS, 2022, 14 (14)
  • [5] Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
    María Belén Giorello
    Francisco Raúl Borzone
    Vivian Labovsky
    Flavia Valeria Piccioni
    Norma Alejandra Chasseing
    Journal of Mammary Gland Biology and Neoplasia, 2021, 26 : 135 - 155
  • [6] Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
    Belen Giorello, Maria
    Raul Borzone, Francisco
    Labovsky, Vivian
    Valeria Piccioni, Flavia
    Alejandra Chasseing, Norma
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2021, 26 (02) : 135 - 155
  • [7] Functional diversity of cancer-associated fibroblasts in modulating drug resistance
    Bu, Luke
    Baba, Hideo
    Yasuda, Tadahito
    Uchihara, Tomoyuki
    Ishimoto, Takatsugu
    CANCER SCIENCE, 2020, 111 (10) : 3468 - 3477
  • [8] The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
    Zheng, Jian
    Hao, Hua
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [9] Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer
    Ozmen, Ece
    Demir, Tevriz Dilan
    Ozcan, Gulnihal
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [10] Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
    Butti, Ramesh
    Khaladkar, Ashwini
    Bhardwaj, Priya
    Prakasam, Gopinath
    CANCER DRUG RESISTANCE, 2023, 6 (01) : 182 - 204